# Empyrean Therapeutics Ltd

## Details

- **Company number:** [11372447](https://find-and-update.company-information.service.gov.uk/company/11372447)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 21 May 2018
- **Registered office:** BUILDING 250, BABRAHAM RESEARCH CAMPUS, BABRAHAM, CB22 3AT
- **Nature of business:** [72110](/sic/72110) Research and experimental development on biotechnology
- **Corporate group:** [Cambridge Prime Ltd](/group/51091) (2 companies)




## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Cambridge Prime Ltd | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 7 Jul 2020 |  |
| Dr Thomas William Henley | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 21 May 2018 | 22 Jul 2019 |



## Accounts

| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 30 Nov 2025 | £1,590,819 | £328,689 | 5 |
| 30 Nov 2024 | £620,964 | £303,593 | 6 |
| 30 Nov 2023 | £540,097 | £2,628,436 | 7 |
| 30 Nov 2022 | £1,037,533 | £484,079 | 11 |
| 30 Nov 2021 | £867,357 | £422,493 | 10 |
| 30 Nov 2020 | £747,005 | £221,352 | 7 |
| 31 May 2019 | - | £161,181 | - |



## Owned by

Empyrean Therapeutics Ltd → [Cambridge Prime Ltd](/company/12572351)